Potential Active Targeting of Gatifloxacin to Macrophages by Means of Surface-Modified PLGA Microparticles Destined to Treat Tuberculosis

  1. Marcianes, P.
  2. Negro, S.
  3. Barcia, E.
  4. Montejo, C.
  5. Fernández-Carballido, A.
Aldizkaria:
AAPS PharmSciTech

ISSN: 1530-9932

Argitalpen urtea: 2020

Alea: 21

Zenbakia: 1

Mota: Artikulua

DOI: 10.1208/S12249-019-1552-3 GOOGLE SCHOLAR